Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.990
-0.210 (-4.04%)
At close: Dec 5, 2025, 4:00 PM EST
5.10
+0.11 (2.20%)
After-hours: Dec 5, 2025, 7:56 PM EST

Cytek Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
6388361,2361,3772,182-
Upgrade
Market Cap Growth
-19.19%-32.38%-10.21%-36.91%--
Upgrade
Enterprise Value
4015739631,0511,806-
Upgrade
Last Close Price
4.996.499.1210.2116.32-
Upgrade
PE Ratio
---534.4941969.36-
Upgrade
Forward PE
-26.14245.0644.39152.95-
Upgrade
PS Ratio
3.244.176.418.3917.06-
Upgrade
PB Ratio
1.692.113.153.245.38-
Upgrade
P/TBV Ratio
1.852.333.493.355.59-
Upgrade
P/FCF Ratio
-38.251952.94-8204.54-
Upgrade
P/OCF Ratio
-32.94234.09-471.36-
Upgrade
EV/Sales Ratio
2.042.864.996.4114.12-
Upgrade
EV/EBITDA Ratio
---1527.81173.67-
Upgrade
EV/EBIT Ratio
----197.22-
Upgrade
EV/FCF Ratio
-26.211522.10-6789.29-
Upgrade
Debt / Equity Ratio
0.070.040.040.04-0.02
Upgrade
Debt / EBITDA Ratio
---4.23-0.19
Upgrade
Debt / FCF Ratio
-0.7822.33--0.20
Upgrade
Asset Turnover
0.400.400.380.330.380.64
Upgrade
Inventory Turnover
1.861.701.521.551.761.96
Upgrade
Quick Ratio
4.305.005.677.9911.886.91
Upgrade
Current Ratio
5.175.866.979.2613.017.86
Upgrade
Return on Equity (ROE)
-3.36%-1.53%-2.97%0.60%1.04%18.38%
Upgrade
Return on Assets (ROA)
-4.36%-2.91%-3.43%-0.23%1.68%5.88%
Upgrade
Return on Capital (ROIC)
-5.35%-3.52%-4.09%-0.27%1.95%7.98%
Upgrade
Return on Capital Employed (ROCE)
-8.20%-5.40%-6.40%-0.40%2.10%7.10%
Upgrade
Earnings Yield
-2.01%-0.72%-0.98%0.19%0.14%-
Upgrade
FCF Yield
-0.92%2.61%0.05%-1.60%0.01%-
Upgrade
Buyback Yield / Dilution
2.85%3.45%2.37%-69.93%-150.13%-16.71%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.